Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
Aug. 3, 2016 Published in the Ripon Advance- Hatch, Upton React to GAO Report on Misaligned Payments for Uncompensated Hospital Costs Sen. Orrin Hatch Unknown
July 14, 2016 Rep. Stewart Secures $300 Million in Grants for Pediatric Residents Rep. Chris Stewart Washington, DC
July 14, 2016 Finance Committee Continues Momentum in Second Session of 114th Congress Sen. Orrin Hatch Washington, DC
July 13, 2016 Hearing of the Senate Committee on Finance: Medicare Access and CHIP Reauthorization Act of 2015: Ensuring Successful Implementation of Physician Payment Reforms- Hatch Opening Statement Sen. Orrin Hatch Washington, DC
July 12, 2016 Hearing of the Senate Committee on Finance: Examining the Stark Law: Current Issues and Opportunities - Hatch Opening Statement Sen. Orrin Hatch Washington, DC
July 12, 2016 Energy Policy Modernization Act of 2015 Sen. Orrin Hatch Washington, DC
July 8, 2016 Rep. Stewart's Statement on Zika Related Death in Utah Rep. Chris Stewart Washington, DC
July 7, 2016 Letter to Gene Dodaro, Comptroller General of the GAO - Moulton Advocates for Better Bipartisan Oversight of National Addiction Services Rep. Rob Bishop Washington, DC
July 7, 2016 Letter to Gene Dodaro, Comptroller General of the GAO - Moulton Advocates for Better Bipartisan Oversight of National Addiction Services Rep. Jason Chaffetz Washington, DC
July 7, 2016 House-Senate Opioid Conference Report Finalized Sen. Orrin Hatch Washington, DC
July 7, 2016 Letter to Gene Dodaro, Comptroller General of the GAO - Moulton Advocates for Better Bipartisan Oversight of National Addiction Services Rep. Chris Stewart Washington, DC
July 7, 2016 Letter to Gene Dodaro, Comptroller General of the GAO - Moulton Advocates for Better Bipartisan Oversight of National Addiction Services Rep. Mia Love Washington, DC
July 6, 2016 Hatch to Hold Finance Hearing on MACRA Sen. Orrin Hatch Washington, DC
July 6, 2016 Letter to the Honorable Andrew W. Cuomo, Governor of New York, the Honorable Elijah Cummings, Ranking Member of the House Oversight and Government Reform Committee and the Honorable Brenda Lawrence, Ranking Member of the Subcommittee on the Interior - Drinking Water Rep. Jason Chaffetz Washington, DC
July 6, 2016 Hearing of the Conference Committee on the Comprehensive Addiction and Recovery Act Sen. Orrin Hatch Washington, DC
July 6, 2016 Letter to the Honorable Gina McCarthy, Administrator of the US Environmental Protection Agency, the Honorable Elijah Cummings, Ranking Member of the House Oversight and Government Reform Committee and the Honorable Brenda Lawrence, Ranking Member of the Subcommittee on the Interior - Drinking Water Rep. Jason Chaffetz Washington, DC
July 5, 2016 Hatch to Hold Finance Hearing on Stark Law Sen. Orrin Hatch Washington, DC
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic Sen. Orrin Hatch Washington, DC
June 30, 2016 Hatch Releases White Paper Discussing Suggestions to Improve Stark Law Sen. Orrin Hatch Washington, DC
June 28, 2016 Hearing of the Senate Committee on Finance- Hatch Statement on Proposed Medicare Part B Demo Sen. Orrin Hatch Washington, DC
June 28, 2016 Letter to the Honorable Sylvia Matthews Burwell, Secretary of Health and Human Services and the Honorable Elijah Cummings, Ranking Member of the House Oversight and Government Reform Committee - ETC Devices Rep. Jason Chaffetz Washington, DC
June 23, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Administration - Rep. Stewart Leads Bi-partisan Effort, Urging FDA to Allow for Office-Use Drug Compounding in Pharmacies Rep. Mia Love Washington, DC
June 23, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Administration - Rep. Stewart Leads Bi-partisan Effort, Urging FDA to Allow for Office-Use Drug Compounding in Pharmacies Rep. Jason Chaffetz Washington, DC
June 23, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Administration - Rep. Stewart Leads Bi-partisan Effort, Urging FDA to Allow for Office-Use Drug Compounding in Pharmacies Rep. Chris Stewart Washington, DC
June 23, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Administration - Rep. Stewart Leads Bi-partisan Effort, Urging FDA to Allow for Office-Use Drug Compounding in Pharmacies Rep. Rob Bishop Washington, DC
June 21, 2016 Hatch to Hold Finance Hearing on Proposed Medicare Part B Demo Sen. Orrin Hatch Washington, DC
June 21, 2016 Lee, Klobuchar Hold Antitrust Subcommittee Hearing on CREATES Act, Bipartisan Legislation to Address Rising Prescription Drug Prices Sen. Michael Lee Washington, DC
June 21, 2016 Lee, Klobuchar Hold Antitrust Subcommittee Hearing on CREATES Act, Bipartisan Legislation to Address Rising Prescription Drug Prices Sen. Michael Lee Washington, DC
June 20, 2016 Hatch Introduces Bipartisan Legislation to Facilitate Research on the Medical Value of Marijuana Sen. Orrin Hatch Washington, DC
June 17, 2016 Gardner, Hatch, Johnson Introduce Amendment to Provide Life-Saving Treatment to Epilepsy Patients Sen. Orrin Hatch Washington, DC
June 17, 2016 Letter to the Honorable Sylvia Matthew Burwell, Secretary of Health and Human Services - Ohio Health CO-OP Rep. Jason Chaffetz Washington, DC
June 17, 2016 Letter to the Honorable Loretta Lynch, Attorney General, the Honorable Elijah Cummings, Ranking Member of the House Oversight and Government Reform Committee, the Honorable Mathew Cartwright, Ranking Member of the Subcommittee on Health Care, Benefits, and Administrative Rules - Ohio Healthcare CO-OP Rep. Jason Chaffetz Washington, DC
June 14, 2016 Economists Praise Sen. Lee's Drug Cost Reduction Bill Sen. Michael Lee Washington, DC
June 9, 2016 Hatch, Wyden and Burr Highlight GAO Work on Medicare Audit and Appeals Process Sen. Orrin Hatch Washington, DC
June 7, 2016 Letter to the Honorable Daniel Levinson, Inspector General and the Honorable Elijah Cummings, Ranking Member of the House Oversight and Government Reform Committee - Oregon Health Exchange Rep. Jason Chaffetz Washington, DC
June 3, 2016 Following Discovery of New Superbug in U.S., Hatch, Bennet, to Introduce Amendment Supporting Development of New Antibiotics Sen. Orrin Hatch Washington, DC
June 2, 2016 Senators Hatch and Markey Call on HHS to Follow Senate Lead in Increasing Access to Opioid Addiction Treatment Sen. Orrin Hatch Unknown
June 1, 2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment Sen. Orrin Hatch Washington, DC
May 19, 2016 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016 Sen. Michael Lee Washington, DC
May 16, 2016 Hatch Statement on Supreme Court Ruling in Favor of Little Sisters of the Poor Sen. Orrin Hatch Washington, DC
May 12, 2016 Letter to the Honorable Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services and the Hon. Jacob Lew, Secretary of the Dept. of the Treasury - On Illegal Obamacare Reinsurance Payments Sen. Orrin Hatch Washington, DC
May 10, 2016 Hatch Releases Updated Report on Physician-Owned Distributorships Sen. Orrin Hatch Washington, DC
May 2, 2016 Letter to the Hon. Andy Slavitt, Actiong Administrator, Centers for Medicare and Medicaid - Prevent Administration's Medicare Experiment Rep. Rob Bishop Washington, DC
May 2, 2016 Letter to the Hon. Andy Slavitt, Actiong Administrator, Centers for Medicare and Medicaid - Prevent Administration's Medicare Experiment Rep. Mia Love Washington, DC
May 2, 2016 Letter to the Hon. Andy Slavitt, Actiong Administrator, Centers for Medicare and Medicaid - Prevent Administration's Medicare Experiment Rep. Chris Stewart Washington, DC
May 2, 2016 Letter to the Hon. Andy Slavitt, Actiong Administrator, Centers for Medicare and Medicaid - Prevent Administration's Medicare Experiment Rep. Jason Chaffetz Washington, DC
April 29, 2016 Hatch, Schatz Introduce Bill Increasing Access to High Quality Health Care in Remote Regions Sen. Orrin Hatch Washington, DC
April 28, 2016 Hearing of the Senate Finance Committee - Hatch Statement on Mental Health Sen. Orrin Hatch Washington, DC
April 28, 2016 Letter to Andrew Slavitt, Acting Administrator of the Centers for Medicare & Medicaid Services - Call for Withdrawal of Proposed Drug Rule for Medicare Part B Sen. Orrin Hatch Washington, DC
April 27, 2016 Letter to Dr. Collins - Call for Improved Data on Child Participation in NIH Clinical Health Trials Sen. Orrin Hatch Washington, DC
April 25, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Association - Lawmakers Demand Information about Obama's Loosening of Abortion Drug Rules Rep. Chris Stewart Washington, DC
April 25, 2016 Letter to Dr. Robert M. Califf, M.D., Commissioner of the Food and Drug Association - Lawmakers Demand Information about Obama's Loosening of Abortion Drug Rules Sen. Michael Lee Washington, DC
April 18, 2016 Letter to Edith Ramirez, Chairwoman of the Federal Trade Commission - Lee, Klobuchar Press FTC On Contact Lens Market Sen. Michael Lee Washington, DC
April 13, 2016 Hatch Bill Targeting Prescription Drug Abuse Heads to President's Desk for Signature Sen. Orrin Hatch Washington, DC
April 12, 2016 House Passes Hatch-Whitehouse Bill to Prevent Illicit Transfer of Prescription Drugs Sen. Orrin Hatch Washington, DC
April 6, 2016 Senate HELP Committee Holds Mark-up for PATH Act to Create Streamlined Antibiotic Approval Pathway Sen. Orrin Hatch Washington, DC
March 29, 2016 Letter to Ms. Sara Rosenbaum, Chair, Medicaid and CHIP Payment and Access Commission - Concerns Surrounding Conflict of Interest Policies Sen. Orrin Hatch Washington, DC
March 29, 2016 Letter to Attorney General Lynch - DOJ's Enforcement of FACE Act Appears Warped and Biased Sen. Michael Lee Unknown
March 18, 2016 Hatch and Whitehouse's Ensuring Patient Access and Effective Drug Enforcement Act Passes Senate Sen. Orrin Hatch Washington, DC
March 15, 2016 Fox News - Republicans Hammer EPA Official Over Flint Water Crisis Rep. Jason Chaffetz Unknown
March 15, 2016 Cochran Cosponsors Pain Prevention, Treatment Research Bill Sen. Orrin Hatch Washington, D.C.
March 11, 2016 The Detroit News - Chaffetz Heads to Flint Ahead of Congressional Hearings Rep. Jason Chaffetz Washington, DC
March 10, 2016 Letter to J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc. - Concerns Regarding Valeant's Lack of Transparency Rep. Jason Chaffetz Washington, DC
March 10, 2016 Hatch Hails Passage of Bill to Curtail Heroin and Opioid Abuse Sen. Orrin Hatch Washington, DC
March 9, 2016 Orphan Drugs Sen. Orrin Hatch Washington, DC
March 9, 2016 Letter to Andy Slavitt, Acting Administrator Centers for Medicare & Medicaid Services - Halt Plans to Cut Medicare Advantage Sen. Orrin Hatch Washington, DC
March 9, 2016 Hatch Statement on the Advancement of MEDTECH Act through HELP Committee Sen. Orrin Hatch Washington, DC
March 9, 2016 Hatch, Bennet, Burr Statement on Advancing Breakthrough Devices Passage Through HELP Committee Sen. Orrin Hatch Washington, DC
March 8, 2016 The Desert News-Chris Stewart: The Zika Virus: Good Intentions Gone Awry Rep. Chris Stewart Washington, DC
March 4, 2016 Letter to Gene Dodaro, Comptroller General of the United States - Transparency Regarding Federal Funding Of Planned Parenthood, Affiliates Sen. Michael Lee Washington, DC
March 4, 2016 Letter to Gene Dodaro, Comptroller General of the United States - Transparency Regarding Federal Funding Of Planned Parenthood, Affiliates Rep. Chris Stewart Washington, DC
Feb. 23, 2016 Hatch Statement on the Confirmation of Robert Califf as FDA Commissioner Sen. Orrin Hatch Washington, DC
Feb. 23, 2016 Hearing of the Senate Committee on Finance - Opening Statement of Sen. Orrin Hatch - Hearing to Examine the Opioid Epidemic Sen. Orrin Hatch Washington, DC
Feb. 23, 2016 Hatch Statement at Finance Committee Hearing Examining the Opioid Epidemic Sen. Orrin Hatch Washington, DC
Feb. 11, 2016 Judiciary Committee Passes Hatch-Whitehouse Bill to Improve Enforcement and Monitoring of Prescription Drugs Sen. Orrin Hatch Washington, DC
Feb. 11, 2016 Hearing of the Senate Finance Committee - Opening Statement of Sen. Hatch, Hearing on HHS's Budget Request Sen. Orrin Hatch Washington, DC
Feb. 10, 2016 Letter to the Honorable Barack Obama, President of the United States - On Zika Virus Rep. Chris Stewart Washington, DC
Feb. 9, 2016 HELP Committee Advances Bipartisan Bill to Help Patients by Facilitating Faster Development of Drugs for Rare Diseases Sen. Orrin Hatch Washington, DC
Feb. 8, 2016 Chronic Care Working Group Releases Comments on Options Paper Sen. Orrin Hatch Washington, DC
Feb. 5, 2016 Letter to Commissioner Ostroff - Urge to Act on Zika Virus Rep. Chris Stewart Washington, DC
Feb. 3, 2016 Forbes - Rise of the Licensing Cartel Sen. Michael Lee Washington, DC
Feb. 3, 2016 Zika Response and Safety Act Rep. Chris Stewart Washington, DC
Jan. 11, 2016 Black, Kelly, Hatch, and Lankford Announce Amicus Brief in Support of Nonprofits' Challenge to HHS Mandate Sen. Orrin Hatch Washington, DC
Dec. 24, 2015 President Signs Reed-backed Bill to Improve Access to Bone Marrow & Cord Blood Treatments and Transplants Sen. Orrin Hatch Washington, DC
Dec. 18, 2015 Letter to Thomas Frieden, Director, Centers for Disease Control - Prescribed Opioids Rep. Jason Chaffetz Washington, DC
Dec. 18, 2015 Hatch, Wyden, Isakson, Warner Release Chronic Care Options Paper Sen. Orrin Hatch Washington, DC
Dec. 17, 2015 Sen. Hatch and Sen. Klobuchar Become Senate Co-Chairs of Rare Disease Congressional Caucus Sen. Orrin Hatch Washington, DC
Dec. 17, 2015 Cord Blood and Bone Marrow Bill Co-Sponsors Applaud House Passage, Urge President to Sign Sen. Orrin Hatch Washington, DC
Dec. 15, 2015 Letter to the Hon. Stephen Ostroff, Acting Commissioner, U.S. Food and Drug Administration - Documents from FDA on Generics Applications Rep. Jason Chaffetz Washington, DC
Dec. 9, 2015 Hatch, Wyden Applaud Introduction of Bipartisan Bill to Overhaul Medicare Audit & Appeals Process Sen. Orrin Hatch Washington, DC
Dec. 7, 2015 Letter to Mr. Andy Slavitt, Acting Administrator, Centers for Medicare and Medicaid Serices - Regarding Medicaid Asset Verification Systems Sen. Orrin Hatch Washington, DC
Dec. 3, 2015 Bipartisan Group of Senators Introduces Bill to Improve Processing and Analysis of DNA Samples for Law Enforcement Purposes Sen. Michael Lee Washington, DC
Dec. 3, 2015 Bipartisan Group of Senators Introduces Bill to Improve Processing and Analysis of DNA Samples for Law Enforcement Purposes Sen. Orrin Hatch Washington, DC
Dec. 2, 2015 Restoring American's Healthcare Freedom Reconciliation Act Sen. Orrin Hatch Washington, DC
Dec. 2, 2015 Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 Sen. Michael Lee Washington, DC
Nov. 30, 2015 Breast Cancer Research Stamp Reauthorization Act of 2015 Rep. Jason Chaffetz Unknown
Nov. 17, 2015 Hearing of the Senate Finance Committee - Opening Statement of Sen. Hatch, Hearing on Physician Owned Distributors: Are They Harmful to Patients and Payers? Sen. Orrin Hatch Washington, DC
Nov. 16, 2015 Letter to the Hon. Sylvia Burwell, Secretary, U.S. Department of Health and Human Services - Obamacare Exchange Notice Sen. Orrin Hatch Washington, DC
Nov. 13, 2015 Letter to Bruce Siegel, President and CEO, America's Essential Hospitals - Input on How to Improve Medicaid Reporting Requirements Sen. Orrin Hatch Washington, DC
Nov. 6, 2015 Letter to the Hon. Andrew Slavitt, Acting Administrator, Centers for Medicare and Medicaid Services - Obamacare Advertising Sen. Orrin Hatch Washington, DC
Skip to top
Back to top